Vitrolife Inc.
$31.3K 38 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Catheter Precision Inc.
Catheter Precision Inc. reported $31,289.50 across General Payments, Research, and Ownership to 40 physicians and teaching hospitals across 41 transactions.
- $31.3K Below-median payer
- All-tracks total
- 41 Below-median volume
- Transactions
- 40 Below-median reach
- Recipients
- −$1.5K
- General Payments vs PY2023
Catheter Precision Inc. reported $31,289.50 across all CMS Open Payments tracks (General + Research + Ownership) to 40 physicians and teaching hospitals in Program Year 2024 - ranking #1461 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,289.50, averaging $782.24 per recipient.
How Catheter Precision Inc.'s $31.3K all-tracks total breaks down
Catheter Precision Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
10/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer catheter-precision-inc Catheter Precision Inc.
$31.3K · #1461/1,925 · 0.0% industry · PY2024
- TOT $31.3K
- RANK #1461
- SHARE 0.0%
- TXN 41
- RCP 40
- CAT 1
- GEN $1.3K
- ΔGEN −$1.5K
- TOP1 10.7%
- PY 2024
Volume peers
Nearest volume peer: Vitrolife Inc. ($31.3K)
Catheter Precision Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Catheter Precision Inc.'s CMS-reported General Payments decreased by $1.5K (−54.3%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: CATHETER PRECISION INC.PY2023: CATHETER PRECISION INC.PY2024: Catheter Precision Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $2,822.51
- PY2024
- $1,289.50
What the Data Shows for Catheter Precision Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Catheter Precision Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
Of the 1 general-payment categories charted below, "Food and Beverage" is the largest at $1.3K across 40 transactions, 100.0% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Food and Beverage" leads Catheter Precision Inc.'s 1-category general-payment breakdown at $1.3K, 100.0% of the reported total.
How Catheter Precision Inc. divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $1.3K | 40 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $572.65 (44.4%) of $1,289.50 in this company's General Payments records across 37 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Catheter Precision Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Dhanunjaya Lakkireddy
$137.95 across 2 reported transactions
- 2
Naga Pothineni
$137.95 across 2 reported transactions
- 3
Gery Tomassoni
$111.10 across 1 reported transactions
- 4
Peter Park
$105.11 across 1 reported transactions
- 5
Benjamin D'Souza
$80.54 across 2 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Catheter Precision Inc.'s spend rank (#1461 of 1,925, bottom 24% by spend) and concentration rank (#1,273 of 1,838, bottom 31% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Abanza Inc. : $3.5K total payments, HHI 546
- Pajunk Medical Systems, LP : $4.4K total payments, HHI 538
- Cagent Vascular INC : $103.5K total payments, HHI 534
- ImmunoGen, Inc. : $95.7K total payments, HHI 533
- TELA Bio, Inc. : $2.1M total payments, HHI 531
- Medistim USA, Inc. : $4.8K total payments, HHI 530
- Catheter Precision Inc. (this company) : $1.3K total payments, HHI 525
- Centinel Spine, LLC : $742.0K total payments, HHI 525
- Roche Diagnostics International Ltd : $376.3K total payments, HHI 524
- Life Spine, Inc. : $327.4K total payments, HHI 523
- Sarepta Therapeutics, Inc. : $2.8M total payments, HHI 522
- Exeltis, USA Inc. : $704.0K total payments, HHI 519
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Catheter Precision Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Catheter Precision Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Catheter Precision Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
ProgenaCare Global, LLC
$31.3K 385 recipients
Compare payment profiles
Atlas Spine, Inc.
$31.3K 17 recipients
Compare payment profiles
Prexion, Inc.
$31.5K 23 recipients
Compare payment profiles
Lupin Inc.
$31.5K 12 recipients
Compare payment profiles
Optos plc
$31.7K 31 recipients
Compare payment profiles
Put this to use
Catheter Precision Inc. ranks #1461 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Catheter Precision Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.